<DOC>
	<DOCNO>NCT01133574</DOCNO>
	<brief_summary>This single rise dose tolerance ( Part A ) follow functional magnetic resonance imaging ( Part B )</brief_summary>
	<brief_title>This Single Ascending Dose Tolerance Study</brief_title>
	<detailed_description>The Part A study parallel design follow second part cross-over design</detailed_description>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Inclusion Criteria BMI 18.0 28.0 kg/m2 , systolic blood pressure 90140 mmHg , diastolic blood pressure 5090 mmHg , heart rate 50 100 beats/min ( inclusive ) , clinically normal safety ECG laboratory result Exclusion Criteria relevant disease , treat SLV354</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Healthy volunteer</keyword>
	<keyword>SLV354</keyword>
	<keyword>Phase I</keyword>
	<keyword>SRDT</keyword>
</DOC>